Earnings Feed
Start Free
Adaptive Biotechnologies Corp·4

Mar 13, 8:52 PM ET

PISKEL KYLE 4

Research Summary

AI-generated summary

Updated

Adaptive Biotechnologies (ADPT) CFO Kyle Piskel Sells Shares

What Happened
Kyle Piskel, CFO of Adaptive Biotechnologies (ADPT), sold 18,672 shares on 2026-03-11 at an average price of $13.17 per share, generating proceeds of $245,910. The Form 4 reports this disposition as a sale and the filing was made on 2026-03-13.

Key Details

  • Transaction date and price: 2026-03-11 — 18,672 shares sold at $13.17 each (total ~$245,910).
  • Transaction type: Sale (reported as open market or private sale).
  • Reason/footnote: Sale was a mandated "sell to cover" to satisfy tax withholding on vested RSUs (per issuer election); not a discretionary trade by the CFO.
  • Shares owned after transaction: Not disclosed on the provided summary of the filing.
  • Filing timeliness: Form 4 filed 2026-03-13 — appears timely (filed within two business days of the transaction).

Context
"Sell to cover" transactions are routine tax-withholding sales tied to RSU vesting and generally do not indicate the insider's market view. This was a tax-driven disposition rather than an independent decision to liquidate holdings.